A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT)

por Wolfe, Sydney, Diven, Marshall A., Marciscano, Ariel E., Zhou, Xi Kathy, Kishan, A. U., Steinberg, M. L., Miccio, Joseph A., Camilleri, Philip, Nagar, Himanshu
Publicado 2023

Telemedicine Perspectives in Radiation Oncology

por Parikh, N.R., Philipson, R., van Dams, R., Chang, E.M., Hegde, J.V., Kishan, A.U., Kaprealian, T.B., Steinberg, M.L., Raldow, A.
Publicado 2021